Halifax VG hospital cleans up bed bugs in dialysis unit room - Nova Scotia ... - CBC.ca
A single room in the dialysis unit at Halifax's Victoria General Hospital site had to be cleaned for bed bugs this week.
John Gillis, a spokesperson for the Nova Scotia Health Authority says a report was received over the weekend that a single room was affected.
"So our housekeeping staff responded to clean it up. We have protocols for how to manage that situation which also involves bringing in an external pest control company," he said.
Gillis says the room was thoroughly cleaned and the company returned on Thursday afternoon to confirm that there were no traces of bed bugs left in the room or the unit.
Gillis couldn't say how often bed bugs are a problem at the hospital.
"I don't often hear of it but they travel with people so, people are coming in and out of the hospital all the time," he said.
Authentidate's Telehealth Solution Featured in Nephrology News Issues(R ... - Consumer Electronics Net
Company News: Page (1) of 1 - 07/23/15
July 23, 2015 --
BERKELEY HEIGHTS, N.J., July 23, 2015 (GLOBE NEWSWIRE) -- Authentidate Holding Corp. (Nasdaq:ADAT), a provider of web-based revenue cycle management applications and telehealth products and services for healthcare organizations was featured this month in an article in Nephrology News & Issues®, a publication that integrates the business and practice of quality kidney care.
The article, Renal Ventures Program to Start Remotely Monitoring Incident Dialysis Patients, written by Rebecca Zumoff, covered the recent announcement that Renal Ventures Management (RVM) would begin remotely monitoring a selection of their dialysis patients using Telehealth Solutions from Authentidate in an effort to decrease hospitalizations and mortality. Each dialysis patient in the program will be enrolled in a specific disease management protocol that will allow case managers to remotely manage and direct patient care.
Authentidate's Telehealth Solution is designed to help patients achieve their goals to get healthy and stay healthy with an easy to use mobile device that captures vital signs, symptoms, and treatment plan compliance in the home and shares the associated data in real time with the patient's care givers via the internet.
George R. Aronoff, MD, Chief Medical Officer of RVM told the publication, "Depending on their co-morbidities, patients may also be supplied with a glucometer, weight scale, BP cuff and oximeter that will record results back to the tablet via Bluetooth and then to a secure clinical portal website hosted by Authentidate. Our case managers and physicians then will access patient information from their PCs by logging on to the clinical portal. The case managers will also be able to interact with patients utilizing a camera on the tablets, if needed. Using remote patient management, we will be able to interact with these patients daily."
Commenting on how patients were being selected he said, "We chose incident patients because, according to USRDS data, they have very high hospitalization and mortality rates."
Aronoff also said they are also considering using the data that they collect to feed advanced decision support tools using predictive analytics to determine who among incident patients are the most at risk for hospitalizations and other adverse events.
Authentidate Holding Corp. is a provider of web-based revenue cycle management applications and telehealth products and services that enable healthcare organizations to coordinate care for patients and enhance related administrative and clinical workflows. Authentidate's products and services enable healthcare organizations to increase revenues, reduce costs and enhance patient care by eliminating paper and manual work steps from clinical and administrative processes. Authentidate's telehealth solutions combine patient vital signs monitoring with a web application that streamlines patient care management. Delivered as Software as a Service (SaaS), customers only require an Internet connection and web browser to access our web-based applications thereby utilizing previous investments in systems and technology. The company's healthcare customers and users include leading homecare companies, health systems, and physician groups. These organizations utilize the company's products and services to coordinate care for patients outside of acute care.
This press release contains forward-looking statements within the meaning of section 27A of the Securities Act of 1933 and section 21E of the Securities Act of 1934. When used in this release, the words "believe," "anticipate," "think," "intend," "plan," "will be," "expect," and similar expressions identify such forward-looking statements. Such statements regarding future events and/or the future financial performance of the company are subject to certain risks and uncertainties, which could cause actual events or the actual future results of the company to differ materially from any forward-looking statement. Such risks and uncertainties include, among other things, the availability of any needed financing, the company's ability to implement its business plan for various applications of its technologies, the impact of competition, the management of growth, and the other risks and uncertainties that may be detailed from time to time in the company's reports filed with the Securities and Exchange Commission. In light of the significant risks and uncertainties inherent in the forward-looking statements included herein, the inclusion of such statements should not be regarded as a representation by the company or any other person that the objectives and plans of the company will be achieved.
Authentidate, Inscrybe and InscrybeMD are registered trademarks of Authentidate Holding Corp. All other trade names are the property of their respective owners.
CONTACT: Media Contacts: Authentidate Holding Corp.
James Carbonara, Hayden IR,
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
(646) 755-7412
Brett Maas, Hayden IR,
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
(646) 536-7331
Related Keywords: HEALTH, SOFTWAREDisease, healthcare, Surgery, Physician, Science, Communications Technology, Internet Technology, Medical, Business, Internet, Web-Based Applications, Other, Medical Professionals,
Source:2015 GlobeNewswire, Inc. . All Rights Reserved
Manjung needs new dialysis machines, not replacements, says assemblyman - The Malaysian Insider
Pantai Remis assemblyman Wong May Ing said that there weren't enough dialysis machines in the Manjung area. – The Malaysian Insider pic by Peter Nunis, July 24, 2015.The Health Ministry has a RM45 million budget for enhancing the national haemodialysis programme, but of this the Manjung district, Perak, will only get three new dialysis machines.
“Two machines will go to Hospital Seri Manjung and one to the health clinic in Pangkor,” said Pantai Remis assemblyman Wong May Ing who said she received the information in a written reply to a question she raised in a recent Perak Assembly meeting in Ipoh.
“These are replacing old dialysis machines at the two centres when, in actual fact, we need more in the district,” she added.
Wong said the number of people suffering from kidney disease here had increased and many of them could not afford dialysis or did not have access to treatment.
However, Wong welcomed the plans by the Perak government to build a dialysis centre in Pantai Remis with four dialysis treatment machines.
Currently, there are seven dialysis centres (excluding the Armed Forces Hospital Lumut) in Manjung, of which three are government-run and four operated by non-government organisations (NGOs). There are 369 registered patients in the area.
Meanwhile, retired teacher Sathya Nandham Siealingam, 63, of Ayer Tawar, who was diagnosed with 30% kidney function in March, felt thankful that he did not have to pay for the treatment.
“Dialysis normally costs between RM250 and RM280 a session, and a patient needs three four-hour sessions a week, so can you imagine if I was not a retired government servant, I have to pay more than RM3,000 a month, which is a tremendous burden for anyone,” he said.
“As a kidney patient I feel that the government has a moral obligation to help those who cannot afford to pay for treatment.” – July 24, 2015.
Researchers Identify Potential New Targets for Treating Kidney Disease - Newswise (press release)
Proteins in the Wnt signaling pathway play a critical role in kidney scarring
Highlight
• Proteins in the Wnt signaling pathway help drive kidney scarring that can lead to chronic kidney disease.
An estimated 26 million people in the United States have chronic kidney disease.
Newswise — Washington, DC (July 23, 2015) — Chronic diseases such as diabetes and hypertension cause injury to the kidneys, which can lead to scarring and the development of chronic kidney disease. By identifying proteins important to this scarring process, researchers now point to a new strategy for possibly preventing kidney failure and the need for dialysis or transplantation in many patients. The findings appear in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
When Benjamin Humphreys MD, PhD (Washington University School of Medicine) and his colleagues examined the complex process of scarring, or fibrosis, in failing kidneys, they discovered that proteins in the Wnt signaling pathway play a critical role in the crosstalk between cells as scarring occurs. Wnt proteins are important in development but are normally turned off in healthy kidneys. When the researchers boosted expression of Wnt proteins in the kidneys of healthy mice, the organs developed fibrosis. “This means that drugs targeting Wnts might be an effective strategy for humans with chronic kidney disease,” said Dr. Humphreys.
The investigators were surprised to find that Wnt proteins cause kidney fibrosis without inflammation. “In the models we typically use to study in the laboratory, and also in human fibrosis, there is always some degree of inflammation, so to not find any was unexpected,” explained Dr. Humphreys. “We conclude that inflammation is not required for the development of kidney fibrosis, and this suggests that purely anti-inflammatory drugs may not be as effective at treating chronic kidney disease.
Study co-authors include Omar Maarouf, MD, Anusha Aravamudhan, BS, Deepika Rangarajan, BS, Tetsuro Kusaba, MD, Victor Zhang, Jeremy Welborn, Daniel Gauvin, BS, Xiuyun Hou, PhD, and Rafael Kramann, MD.
Disclosures: Dr. Humphreys has received research support in the past from Evotec AG for the study of kidney fibrosis, but those funds did not support this project. The authors reported no other financial disclosures.
The article, entitled “Paracrine Wnt1 Drives Interstitial Fibrosis without Inflammation by Tubulointerstitial Cross-Talk,” will appear online at http://jasn.asnjournals.org/ on July 23, 2015. The content of this article does not reflect the views or opinions of The American Society of Nephrology (ASN). Responsibility for the information and views expressed therein lies entirely with the author(s). ASN does not offer medical advice. All content in ASN publications is for informational purposes only, and is not intended to cover all possible uses, directions, precautions, drug interactions, or adverse effects. This content should not be used during a medical emergency or for the diagnosis or treatment of any medical condition. Please consult your doctor or other qualified health care provider if you have any questions about a medical condition, or before taking any drug, changing your diet or commencing or discontinuing any course of treatment. Do not ignore or delay obtaining professional medical advice because of information accessed through ASN. Call 911 or your doctor for all medical emergencies. Founded in 1966, and with more than 15,000 members, the American Society of Nephrology (ASN) leads the fight against kidney disease by educating health professionals, sharing new knowledge, advancing research, and advocating the highest quality care for patients.
Log in to explore the world's most comprehensive database of dialysis centres for free! 
Professional dialysis recruitment
Pantai Remis assemblyman Wong May Ing said that there weren't enough dialysis machines in the Manjung area. – The Malaysian Insider pic by Peter Nunis, July 24, 2015.The Health Ministry has a RM45 million budget for enhancing the national haemodialysis programme, but of this the Manjung district, Perak, will only get three new dialysis machines.
